All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. revenue reports

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. financial reports, Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. annual revenue in 2024. When does Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. report revenue?
Add to widgets
Added to widgets

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. total revenue, net income and dynamics of changes in yuan today

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. current income and income for the latest reporting periods. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. net income is now 10 488 394 ¥. These are the main financial indicators of Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.. The financial graph of Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. displays the online status: net income, net revenue, total assets. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. Information on Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. net income on the chart on this page is drawn in blue bars.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021 153 160 950 ¥ +4.29 % ↑ 10 488 394 ¥ -46.0457 % ↓
31/12/2020 118 037 364 ¥ +6.37 % ↑ -151 312 782 ¥ -
30/09/2020 102 624 899 ¥ -26.82 % ↓ -13 495 349 ¥ -200.2726 % ↓
30/06/2020 69 674 197 ¥ -40.612 % ↓ -14 978 087 ¥ -339.338 % ↓
30/09/2019 140 237 067 ¥ - 13 458 666 ¥ -
30/06/2019 117 320 449 ¥ - 6 258 133 ¥ -
31/03/2019 146 866 878 ¥ - 19 439 388 ¥ -
31/12/2018 110 964 726 ¥ - -204 398 288 ¥ -
Show:
to

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. financial report charts

The dates of the latest financial statements of Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.: 31/12/2018, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest date of the financial report of Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. is 31/03/2021. Gross profit Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. is 95 468 193 ¥

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. quarterly report dates

Cost of revenue Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. is the total cost of producing and distributing of products and services of a company. Cost of revenue Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. is 57 692 757 ¥ Total revenue Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. is 153 160 950 ¥ Operating income Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. is 15 297 876 ¥

Net income Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. is 10 488 394 ¥ Current assets Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. is 654 987 502 ¥ Total assets Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. refers to the total amount of assets owned by a person or entity. Total assets Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. is 1 663 726 717 ¥

31/03/2021 31/12/2020 30/09/2020 30/06/2020 30/09/2019 30/06/2019 31/03/2019 31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
95 468 193 ¥ 35 383 122 ¥ 56 403 723 ¥ 26 400 399 ¥ 95 882 915 ¥ 70 022 774 ¥ 103 115 278 ¥ 59 946 549 ¥
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
57 692 757 ¥ 82 654 242 ¥ 46 221 176 ¥ 43 273 798 ¥ 44 354 152 ¥ 47 297 675 ¥ 43 751 600 ¥ 51 018 177 ¥
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
153 160 950 ¥ 118 037 364 ¥ 102 624 899 ¥ 69 674 197 ¥ 140 237 067 ¥ 117 320 449 ¥ 146 866 878 ¥ 110 964 726 ¥
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - 140 237 067 ¥ 117 320 449 ¥ 146 866 878 ¥ 110 964 726 ¥
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
15 297 876 ¥ -49 773 013 ¥ -15 944 328 ¥ -28 641 829 ¥ 3 190 423 ¥ -10 343 191 ¥ 26 031 072 ¥ -34 263 623 ¥
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
10 488 394 ¥ -151 312 782 ¥ -13 495 349 ¥ -14 978 087 ¥ 13 458 666 ¥ 6 258 133 ¥ 19 439 388 ¥ -204 398 288 ¥
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
11 644 432 ¥ 13 141 672 ¥ 5 047 650 ¥ 5 626 594 ¥ 8 556 862 ¥ 6 607 185 ¥ 4 314 377 ¥ 6 489 635 ¥
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
137 863 074 ¥ 167 810 377 ¥ 118 569 227 ¥ 98 316 026 ¥ 137 046 644 ¥ 127 663 640 ¥ 120 835 806 ¥ 145 228 349 ¥
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
654 987 502 ¥ 647 647 367 ¥ 926 245 714 ¥ 914 139 461 ¥ 944 302 887 ¥ 920 596 106 ¥ 916 797 156 ¥ 911 470 329 ¥
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
1 663 726 717 ¥ 1 672 903 301 ¥ 1 543 104 313 ¥ 1 547 539 841 ¥ 1 648 557 462 ¥ 1 635 820 754 ¥ 1 642 608 774 ¥ 1 648 594 024 ¥
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
219 403 276 ¥ 106 780 573 ¥ 382 446 373 ¥ 705 396 904 ¥ 189 878 832 ¥ 191 187 310 ¥ 203 469 203 ¥ 145 164 499 ¥
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 119 966 856 ¥ 120 688 809 ¥ 133 734 965 ¥ 164 414 932 ¥
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 128 222 195 ¥ 128 944 148 ¥ 141 990 304 ¥ 167 414 932 ¥
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 7.78 % 7.88 % 8.64 % 10.16 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
1 316 606 955 ¥ 1 306 118 562 ¥ 1 457 431 348 ¥ 1 470 926 698 ¥ 1 520 335 267 ¥ 1 506 876 603 ¥ 1 500 618 471 ¥ 1 481 179 085 ¥
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - -2 739 379 ¥ 9 454 843 ¥ 46 256 241 ¥ 24 972 821 ¥

Last revenue report of Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. was 31/03/2021. According to last financial report total revenue in Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. was 153 160 950 yuan and changed by +4.29% since last year. Net income in Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. was 10 488 394 ¥ in last quartal, net income changes to -46.0457%.

Current cash Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. - the sum of all of the cash a company has on the date of report. Current cash Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. is 219 403 276 ¥

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. stocks data

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. financials